HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation

Autor: Diego Rincón, Aránzazu Caballero-Marcos, Ainhoa Fernández-Yunquera, Lucia Dieguez, Cristina Navarrete, Ana Clemente, Rafael Bañares Cañizares, Magdalena Salcedo, Mario Romero-Cristóbal, Marta Puerto, Fernando Diaz-Fontenla, Pilar Catalán, José-Ángel López-Baena
Rok vydání: 2021
Předmět:
Zdroj: Transplant International. 34:2214-2225
ISSN: 1432-2277
0934-0874
Popis: The increased risk of cardiovascular disease (CVD) conferred by hepatitis C virus (HCV) is especially relevant after liver transplantation (LT), but its mechanism is still not well defined. This study aimed to evaluate the influence of HCV eradication in inflammatory and endothelial activation markers after LT. We evaluated inflammatory (TNF-alfa, IL-6, IL-8, and MCP-1) and endothelial activation (E-selectin, ICAM-1, VCAM-1, and MMP-9) markers before and after eradication in 45 LT recipients with HCV infection (LT+/HCV+) and 44 non-transplanted HCV-infected patients (LT-/HCV+). We also considered an additional group of 40 LT recipients without HCV infection (LT+/HCV-). LT+/HCV+ patients presented a higher endothelial activation status before eradication compared with LT+/HCV- patients. However, levels of E-selectin, ICAM-1, VCAM-1, and MMP-9 were comparable between LT+/HCV+ and LT-/HCV+ patients before eradication. HCV eradication decreased ICAM-1 (5466.55 pg/ml vs. 3354.88 pg/ml, P
Databáze: OpenAIRE